Italy Microfluidics Market Size & Outlook, 2023-2030

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.

Medical was the largest segment with a revenue share of 84.11% in 2023. Horizon Databook has segmented the Italy microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.

Italy is one of the emerging European markets for microfluidics technology as well as its applications. This is evident by the growing interest of researchers in this arena. For instance, in March 2021, researchers at the University of Rome Tor Vergata, Rome, Italy published a study describing the use of organ-on-chip (OOC) platforms for on coimmunology applications. The study further stated the impact of OOC in the field of on coimmunology as well as the role of microfluidics systems in the advancements based on the complexity of the tumor microenvironment. Similarly, in October 2018, a team of researchers at the Department of Information Technology of the University of Pisa and Monash University developed a miniaturized artificial liver consisting of microfluidic silicon chips. This research was published in Advanced Functional Materials. 

This mini-organ is based on nanotechnologies and can be used to test various drug effects. Such research initiatives are expected to boost the adoption of microfluidic technologies in various applications, thereby driving the market. In January 2021, LumiraDx announced the approval of LumiraDx SARS-CoV-2 Antigen Test, which is based on a microfluidics-based immunofluorescence technique. In addition, the Italian Association for Clinical Microbiology issued guidelines supporting the use of next-generation microfluidics technology for SARS-CoV-2 testing. Such factors are expected to boost market growth. Moreover, companies in Italy are expanding their product portfolio of microfluidics components. For instance, BiomimX S.r.l. is an Italian company that offers products for building organ-on-chip models. Its products include uBeat Platform, uBeat Stretch, uBeat Compress, and uCase. This is expected to increase the accessibility to microfluidics components in the country, further contributing to market revenue.